Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. (CRDL) Stock Overview

Explore Cardiol Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRDL●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.86
$0.10(5.10%)
U.S. Market opens in 64h 57m

Cardiol Therapeutics Inc. (CRDL)

Meyka AI Score

Z

Key Financials

Market Cap217.3M
P/E Ratio-7.30
EPS (TTM)$-0.25
ROE-1.94%
Fundamental Analysis

AI Price Forecasts

1 Month$1.82
3 Months$1.21
1 Year Target$0.55

CRDL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cardiol Therapeutics Inc. (NASDAQ: CRDL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cardiol Therapeutics Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CRDL on the NASDAQ shows an RSI of 80.83, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $0.55 for the NASDAQ listing.

Key metrics behind Cardiol Therapeutics Inc.'s NASDAQ-traded stock include a P/E ratio of -7.30 and a market capitalization of 217.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CRDL on the NASDAQ.

Price Performance (NASDAQ: CRDL)

1-Day Change
-1.33%
5-Day Change
7.51%
1-Month Change
50.00%
3-Month Change
41.98%
6-Month Change
86.00%
Year-to-Date (YTD) Change
95.009%
1-Year Change
58.97%
3-Year Change
87.90%
5-Year Change
-38.61%
All-Time (Max) Change
-50.29%

Contact Information

https://www.cardiolrx.com
289 910 0850
2265 Upper Middle Road East, Oakville, ON, L6H 0G5

Company Facts

180 Employees
IPO DateJan 15, 2019
CountryCA
Actively Trading

Frequently Asked Questions